Table 2 Antihypertensive treatment and co-medication at baseline
Intention to treat | Per protocol | |||
|---|---|---|---|---|
Ramipril (n = 1,350) | Diuretic (n = 661) | Ramipril (n = 1,029) | Diuretic (n = 478) | |
Antihypertensive drugs | ||||
Ramipril (%) | 76.2 | 0 | 100.0 | 0 |
CCB (%) | 17.3 | 13.8 | 15.3 | 0 |
Diuretic (%) | 0 | 72.3 | 0 | 100.0 |
Betablocker (%) | 0.3 | 0 | 0 | 0 |
Central acting AH (%) | 3.3 | 2.0 | 2.9 | 1.7 |
Alphablockers (%) | 1.9 | 1.4 | 1.9 | 0.8 |
Co-Medication | ||||
Statins (%) | 19.3 | 17.7 | 17.7 | 16.7 |
Anticoagulants (%) | 3.2 | 5.4 | 2.8 | 5.0 |
Thienopyridines (%) | 2.0 | 1.4 | 1.7 | 1.5 |
Aspirin (%) | 21.7 | 20.4 | 20.5 | 18.4 |